Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 2 Interventional

ENACT: A Study of ENX-101 as Adjunctive Treatment in Patients With Focal Seizures

ClinicalTrials.gov ID: NCT05481905

Public ClinicalTrials.gov record NCT05481905. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 26, 2026, 9:30 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

The ENACT Trial: A Randomized, Double-blind, Placebo-controlled Adjunctive Treatment Trial to Evaluate the Efficacy and Safety of ENX-101 in Patients With Focal (Partial Onset) Seizures

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The ENACT trial is designed to evaluate the efficacy and safety of ENX-101 administered adjunctively to current therapy in reducing seizure frequency in patients diagnosed with focal (partial onset) epilepsy and treated with 1 to 4 antiseizure medications yet still experiencing seizures.

Study identification

NCT ID
NCT05481905
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 2
Lead sponsor
Engrail Therapeutics INC
Industry
Enrollment
Not listed

Conditions and interventions

Conditions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 2022 (Estimated)
Primary completion
Sep 2024 (Estimated)
Completion
Dec 2024 (Estimated)
Last update posted
Jul 6, 2023

2022 – 2024

United States locations

U.S. sites
38
U.S. states
22
U.S. cities
34
Facility City State ZIP Site status
Barrow Neurological Institute Phoenix Arizona 85013 —
University of Arizona Tucson Arizona 85724 —
Rancho Research Institute at Rancho Los Amigos National Rehabilitation Center Downey California 90242 —
University of Colorado Aurora Colorado 80045 —
University of Florida Research Institute of Orlando Gainesville Florida 32611 —
Royal Care Medical Research Corporation Miami Florida 33032 —
University of Miami Miami Florida 33136 —
D&H National Research Centers Miami Florida 33155 —
S&G Research Center Corp. Miami Florida 33155 —
Florida Hospital Orlando Florida 32803 —
Comprehensive Neurology Clinic Orlando Florida 32825 —
Emory University School of Medicine Atlanta Georgia 30322 —
Hawaii Pacific Neuroscience Honolulu Hawaii 96817 —
OSF HealthCare Illinois Neurological Institute Peoria Illinois 61603 —
University of Kansas Kansas City Kansas 66160 —
Saint Joseph Health System Lexington Kentucky 40504 —
Maine Medical Partners Neurology Scarborough Maine 04074 —
University of Maryland Medical Center Baltimore Maryland 21201 —
Mid-Atlantic Epilepsy and Sleep Center Bethesda Maryland 20817 —
University of Michigan Ann Arbor Michigan 48109 —
Oakland University William Beaumont School of Medicine Farmington Hills Michigan 48334 —
SRI International Plymouth Michigan 48170 —
Advanced Clinical Research Center Bridgeton Missouri 63044 —
Washington University School of Medicine St Louis Missouri 63110 —
Somnos Clinical Research/Neurology Associates Lincoln Nebraska 68510 —
Northeast Regional Epilepsy Group Hackensack New Jersey 07601 —
Institute of Neurology and Neurosurgery at Saint Barnabas LLC Livingston New Jersey 07039 —
Donald and Barbara Zucker School of Medicine at Hofstra/Northwell New York New York 10016 —
University of Rochester Rochester New York 14618 —
Montefiore Medical Center The Bronx New York 10467 —
Atrium Health Chapel Hill North Carolina 28204 —
Duke University School of Medicine Durham North Carolina 27710 —
NeuroScience Research Center, LLC Canton Ohio 44718 —
Thomas Jefferson University Philadelphia Pennsylvania 42101 —
University of Pittsburgh Pittsburgh Pennsylvania 15213 —
DJL Clinical Research Rock Hill South Carolina 29732 —
Mt. Olympus Medical Research Sugar Land Texas 77479 —
University of Virginia Charlottesville Virginia 22908 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05481905, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 6, 2023 · Synced Oct 26, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05481905 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →